Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease-Reference-Cited by-同舟云学术

Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease

Published:2017-09 Issue: Volume:117 Page:48-56
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Alongi Filippo,Arcangeli Stefano,Triggiani Luca,Mazzola Rosario,Buglione di Monale e Bastia Michela,Fersino Sergio,Baiguini Anna,Jereczek-Fossa Barbara Alicja,Magrini Stefano Maria

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference44 articles.

1. Stereotactic body radiotherapy in the treatment of adrenal metastases;Ahmed;Am. J. Clin. Oncol.,2013

2. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: is RCC truly radioresistant?;Amini;Pract. Radiat. Oncol.,2015

3. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma;Balagamwala;J. Neurosurg. Spine,2012

4. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma;Beitler;Am. J. Clin. Oncol.,2004

5. Stereotactic body radiation therapy: the report of AAPM Task Group 101;Benedict;Med. Phys.,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?;Clinical Oncology;2023-03

2. The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group;Clinical & Experimental Metastasis;2021-11-08

3. Efficacy and safety of tyrosine kinase inhibitors alone or in combination with radiation therapy for metastatic renal cell carcinoma;Medicine;2021-08-20

4. Oligometastasis and local ablation in the era of systemic targeted and immunotherapy;Radiation Oncology;2020-05-04

5. MR-guidance in clinical reality: current treatment challenges and future perspectives;Radiation Oncology;2019-06-03